SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Cytokinetics, Incorporated ( CYTK)
An SI Board Since April 2004
Posts SubjectMarks Bans Symbol
405 30 0 CYTK
Emcee:  mopgcw Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
180Huh? <i>We maintain our 12-month price target of $9, which is based on a Steve Lokness-8/12/2007
179gs: Cytokinetics, Inc. (CYTK): Cytokinetics 2Q2007 Earnings 52-Week Range US$9-mopgcw-8/12/2007
178mstar: Cytokinetics CYTK announced second-quarter results Tuesday that were in mopgcw-8/1/2007
177other than they continue to pi** away money on the ispenisib trials?? they lookmopgcw-7/31/2007
176>>Cytokinetics, Incorporated Reports Second Quarter 2007 Financial Resultstuck-7/31/2007
175Cytokinetics Rated New `Outperform' at Credit Suisse :CYTK US 2007-07-19 0mopgcw-7/20/2007
174I think the strategy here is to wait until those results GS points to come out, tuck-6/29/2007
173amgn is a nice hole card a la tularik...especially given their needy situation tmopgcw-6/28/2007
172couldn't pry shares out of my hands, this capitalization. so I guess I'scaram(o)uche-6/28/2007
171it is disappointing on a number of levels for sure. If it trades down a lot on mopgcw-6/28/2007
170Cytokinetics Announces Data From Phase II Clinical Trial of Ispinesib in Breast mopgcw-6/28/2007
169worst possible result..... crappy results from all the trials, but they'vescaram(o)uche-6/28/2007
168my understanding is that ispensib and sb-74392 are due to have some results latemopgcw-6/21/2007
167I'm a little confused, too. I don't know who is currently carrying the tuck-6/21/2007
166Tuck; What does this mean; <i>The companies have now agreed to extend theSteve Lokness-6/21/2007
165>>Cytokinetics Announces Second Extension of Research Term Under Collaboratuck-6/21/2007
164Jim Sabry, you're a chicken-shit little weasel. (re. your form 4) Best! Rscaram(o)uche-6/12/2007
163form 4 out.... <i>The sale reported in this Form 4 were effected pursuantscaram(o)uche-5/31/2007
162gs: Cytokinetics, Inc. (CYTK): CYTK: Phase 2 with heart failure agent initiated,mopgcw-4/26/2007
161and, btw..... >> Ill be watching for further weakness as a buying op <scaram(o)uche-4/26/2007
160Yeah, your take is pretty much my take. GSK doesn't see it flying, but has scaram(o)uche-4/26/2007
159Not that I'm a fan of ispinesib, but I read the PR and am having difficulty tuck-4/26/2007
158event day today, huge block drops (wasn't watching) and then quarterly reporscaram(o)uche-4/26/2007
157Cytokinetics Announces Initiation of Phase II Clinical Trials Program for CK-182scaram(o)uche-4/12/2007
156J&J, Otsuka drugs fail heart trials Johnson & Johnson's controversidr.praveen-3/26/2007
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News